Literature DB >> 21191182

CD47 applies the brakes to angiogenesis via vascular endothelial growth factor receptor-2.

Sukhbir Kaur, David D Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21191182     DOI： 10.4161/cc.10.1.14324

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  18 in total

Review 1.  The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.

Authors:  David D Roberts; Thomas W Miller; Natasha M Rogers; Mingyi Yao; Jeffrey S Isenberg
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

Review 2.  Thrombospondin-1 in ocular surface health and disease.

Authors:  William Foulsham; Thomas H Dohlman; Sharad K Mittal; Yukako Taketani; Rohan Bir Singh; Sharmila Masli; Reza Dana
Journal:  Ocul Surf       Date:  2019-06-05       Impact factor: 5.033

3.  Deletion of heart-type cytochrome c oxidase subunit 7a1 impairs skeletal muscle angiogenesis and oxidative phosphorylation.

Authors:  Icksoo Lee; Maik Hüttemann; Jenney Liu; Lawrence I Grossman; Moh H Malek
Journal:  J Physiol       Date:  2012-08-06       Impact factor: 5.182

4.  Selective blockade of tumor angiogenesis.

Authors:  Amit Chaudhary; Brad St Croix
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

5.  Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation.

Authors:  David R Soto-Pantoja; Jeff S Isenberg; David D Roberts
Journal:  J Genet Syndr Gene Ther       Date:  2011-09-26

Review 6.  Integration of pro- and anti-angiogenic signals by endothelial cells.

Authors:  Shideh Kazerounian; Jack Lawler
Journal:  J Cell Commun Signal       Date:  2017-12-20       Impact factor: 5.782

Review 7.  Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47.

Authors:  David R Soto-Pantoja; Erica V Stein; Natasha M Rogers; Maryam Sharifi-Sanjani; Jeffrey S Isenberg; David D Roberts
Journal:  Expert Opin Ther Targets       Date:  2012-10-27       Impact factor: 6.902

8.  CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.

Authors:  Kazumichi Yoshida; Hironori Tsujimoto; Kouji Matsumura; Manabu Kinoshita; Risa Takahata; Yusuke Matsumoto; Shuichi Hiraki; Satoshi Ono; Shuhji Seki; Junji Yamamoto; Kazuo Hase
Journal:  Cancer Med       Date:  2015-06-16       Impact factor: 4.452

9.  The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells.

Authors:  Lakshmi Venkatraman; Lisa Tucker-Kellogg
Journal:  Liver Int       Date:  2013-06-26       Impact factor: 5.828

10.  Predictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissue.

Authors:  Jennifer A Rohrs; Christopher D Sulistio; Stacey D Finley
Journal:  NPJ Syst Biol Appl       Date:  2016-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.